@article{article, title = {{Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}}, url = {{http://eprints.whiterose.ac.uk/137968/ }}, year = {{2018}}, month = {{9}}, author = {{Tappenden P and Simpson E and Hamilton J and Pollard D and Clowes M and Kaltenthaler E and Meiklejohn D and Morley N}}, doi = {{10.1007/s40273-018-0713-7}}, journal = {{PharmacoEconomics}}, note = {{Accessed on 2025/08/14}}}